An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer
Clinical trial NCT07072013 · COMPLETED
Trial details
- NCT number
- NCT07072013
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-08
- Primary completion
- 2025-04-24
- Enrollment
- 1937
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.